RAPT Therapeutics, Inc. (RAPT) Tops Q3 EPS by 9c

RAPT Therapeutics, Inc. (NASDAQ: RAPT) reported Q3 EPS of ($0.47), $0.09 better than the analyst estimate of ($0.56).

For earnings history and earnings-related data on RAPT Therapeutics, Inc. (RAPT) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Eli Lilly & Co. (LLY) Declares $1.73 Quarterly Dividend; 0.6% Yield
• 3Knights Dynamics files for IPO on Nasdaq at $4-$5 per share